Stem Cell Clinic

stem cell therapy @ kapuso jessica soho – Video

By Uncategorized


stem cell therapy @ kapuso jessica soho
LAMININE It #39;s not often that the perfect super-supplement with the perfect story comes around, but the story of Laminine is far from a mythical tale. As far back as 1929, a Medical Doctor in Canada discovered a way to extract the #39;life-essence #39; of a nine day old fertilized avian egg. Through research, it was found that on exactly the ninth day, all the ingredients necessary to create life are at its #39; highest level. In fact, the life-giving proteins are so potent at this stage that a live chick is hatched a mere two weeks thereafter. This method of extraction and freeze-drying processes proved to be a historical monumental success for this Medical Doctor #39;s patients. 09333737867 for infoFrom:xpalfredViews:1 1ratingsTime:12:00More inHowto Style

View post:
stem cell therapy @ kapuso jessica soho - Video

The Rejuvenare Experience .mov – Video

By Uncategorized


The Rejuvenare Experience .mov
Patient Jerry and his wife discuss their Rejuvenare experience in Jerry receiving stem cell therapy for Parkinson #39;s disease. They are very impressed with how fantastic the experience has been and wonders how Rejuvenare can offer such excellent services to its patient clients.From:rejuvenareViews:0 0ratingsTime:01:11More inEducation

Excerpt from:
The Rejuvenare Experience .mov - Video

The Princess Margaret BMT Program Chooses Remedy Informatics' Blood and Marrow Transplant & Cell Therapy Solutions to …

By Uncategorized

Princess Margaret Cancer Program will implement ComprehensiveBMT and Investigate Cell Therapy to continue leading role in cancer care and research

SALT LAKE CITY , Nov. 14, 2012 /CNW/ - Remedy Informatics, the leading provider of registries and research informatics software for Life Science and Translational Research and Healthcare, today announced the Princess Margaret Cancer Centre at University Health Network in Toronto has selected ComprehensiveBMT and Investigate Cell Therapy, two of Remedy's innovative clinical informatics solutions.

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

"The Princess Margaret is one of the largest comprehensive cancer facilities in the world with the largest Blood and Marrow Transplant program in Canada and a gold standard cancer research facility," said Gary Kennedy , Founder and CEO of Remedy Informatics. "Both InvestigateCT and ComprehensiveBMT offer unmatched integration of information to improve treatment outcomes by aggregating, mapping, harmonizing and analyzing data across clinical and scientific disciplines. Valuable information will give valuable insights into patient safety, patient survivorship, and quality improvement for transplant physicians, nurses and researchers."

Built on Remedy's flagship Mosaic Platform, InvestigateCT and ComprehensiveBMT offer the Princess Margaret the world's first and only truly integrated research management system. In addition to combining blood and marrow registries with cell therapy laboratories and biobanks, clinicians and researchers will have an unprecedented view of their data through the Mosaic Ontology, which aggregates, maps and harmonizes the data to facilitate pattern recognition. Together researchers are able to manage and aggregate more data sources, across disciplines, including next-generation sequencing, cross-disease registries, LIMS and the Blood and Marrow Transplant Program to advance research of cell therapies, blood and marrow transplantation, and related diseases.

"The future of patient care and innovative research in blood and marrow transplantation requires rapid data analysis to track and improve patient outcomes. We are confident Remedy Informatics can meet our needs," said Dr. John Kuruvilla , MD, FRCP(C), director, Clinical Program, Blood and Marrow Transplant program at the Princess Margaret . "We foresee better information management as the cornerstone for improving patient outcomes in hematologic malignancies."

The Princess Margaret BMT program has an international reputation as a global leader in clinical and research programs and as a gold standard in transplant technologies like Apheresis collections for peripheral stem cell transplant infusions and Extracorporeal Photopheresis for selected graft-vs-host conditions. Over the next year, Remedy will work with the Princess Margaret BMT program to implement InvestigateCT, the world's first Integrated Research Management System designed for cancer centers involved in clinical research using cell therapies. InvestigateCT will facilitate multi-directional data flow throughout the BMT program, cell therapy labs and biobanks to improve real-time analytics, therapies, patient safety, and quality across the transplant care pathway as well as long-term patient survivorship for patients who are living longer and healthier lives.

Remedy serves a wide range of leading Life Science and Translational Research institutions across the country, including the Huntsman Cancer Institute at the University of Utah, Cleveland Clinic's Bariatric and Metabolic Institute and Heart and Vascular Institute, the American Joint Replacement Registry, Baylor Health Care System, and many more.

For more information about Investigate Cell Therapy or ComprehensiveBMT, or Remedy's leading patient registry technology, please visit our website, http://www.remedyinformatics.com. InvestigateCT is for research use only and is not intended for clinical or cell processing purposes.

About Remedy Informatics, Inc.

More here:
The Princess Margaret BMT Program Chooses Remedy Informatics' Blood and Marrow Transplant & Cell Therapy Solutions to ...

cord blood bank | Cord Blood – Video

By Stem Cell Treatment


cord blood bank | Cord Blood
http://www.cordbloodrecommendation.com This blood is rich in stem cells. The cells in cord blood being younger, they adapt more easily and hence a perfect match is not required. Advocates of public banking say that many problems developed by children are genetic and cannot be treated with their own blood store which contains the same genes. However, more research is required to determine if humans would benefit from mesenchymal stem cells. ""Cancer, which was supposed to be an incurable disease, can now be cured if detected at the right time. If the amount is less, the collected cord blood is used for scientific researches. Within an hour of receiving the stem cell treatment, she was able to turn her head and partially lift her arms. There are people who are against this practice as well and there are many opinions supporting it too therefore it is best to consult your doctor regarding this issue and get the right advice. Umbilical cord blood banking is beneficial because the blood contains valuable stem cells that can be put into the body to fight off infections and diseases. ""Stem cells are a hot topic among the medical community, the government, and expecting parents around the nation. A patient who receives a stem cell transplant using stem cells from a family member is recognized as the best treatment option for hematopoietic (blood-forming) reconstitution. These cells have a unique capability of ""adjusting in any environment inside the body"". This base cell becomes what ...From:BuscoFincaRaizcomarViews:0 0ratingsTime:01:18More inScience Technology

See the original post:
cord blood bank | Cord Blood - Video

Rejuvenare – I don’t have time to wait for approval in the US – Video

By Stem Cell Treatment


Rejuvenare - I don #39;t have time to wait for approval in the US
Patient Jerry relates why he chose Rejuvenare stem cell therapy to treat Parkinson #39;s outside the US. Although he #39;d earlier been successful keeping the disease #39;s progression slowed, they were no longer effective for him and he was told it would be about 10 years before this procedure was approved in the USFrom:rejuvenareViews:0 0ratingsTime:01:24More inEducation

Go here to read the rest:
Rejuvenare - I don't have time to wait for approval in the US - Video

BioTime and Subsidiary LifeMap Sciences Announce the Launch of LifeMap BioReagents™ Portal

By Stem Cell Treatment

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences have announced the launch of LifeMap BioReagents (http://bioreagents.lifemapsc.com/), a new portal offering researchers access to BioTimes research product lines including PureStem human progenitor cell lines, PureStem packages, clinical and research grade human embryonic stem cell lines (hES), HyStem hydrogels, culture media, and cell differentiation kits.

There has been growing interest in the PureStem and hES cell lines

LifeMap Sciences will be the principle marketing and sales arm for BioTimes cell-based products and related reagents for the research community in academia, research hospitals, and biotech and pharma companies. LifeMap Sciences holds the exclusive, worldwide license to market GeneCards (www.genecards.org), with over 12 million page visits per year from hundreds of thousands of unique users worldwide, and MalaCards (www.malacards.org), and plans to launch LifeMap Discovery, its database for biomedical and stem cell research, later this quarter.

LifeMap BioReagents is integrated with the GeneCards, MalaCards, and LifeMap Discovery databases, thereby providing a large number of biomedical researchers accessing these databases a means of identifying stem cell reagents that can enhance research and discovery efforts in a variety of fields, including stem cell research, developmental biology, mechanisms of various human diseases, drug discovery and therapeutic discovery and development.

There has been growing interest in the PureStem and hES cell lines, stated Yaron Guan-Golan, Head of Marketing at LifeMap Sciences. Our ability to provide stable, characterized, pure, and scalable cell lines to the research community and to industry is a big step forwardnot only in the study of stem cells, but also in the understanding of cellular and developmental biology and human disease, and in the discovery of new therapies. Together with our LifeMap Discovery database, researchers will now be able to immediately obtain access to cutting-edge embryonic stem and progenitor cell lines as part of a wealth of developmental and stem cell information that they need for research.

About LifeMap Sciences, Inc.

LifeMap Sciences (www.lifemapsc.com) core technology and business is based on its integrated database suite, the discovery platform for biomedical and stem cell research. This platform includes GeneCards, the leading human gene database; LifeMap Discovery, the database of embryonic development, stem cell research, and regenerative medicine; and MalaCards, the human disease database. LifeMap Sciences also markets PanDaTox, an innovative, recently developed, searchable database that can aid in the discovery of new antibiotics and biotechnologically beneficial products.

In addition to database offerings, LifeMap Sciences is BioTimes principal marketing subsidiary for research products, including PureStem human progenitor cell lines, GMP human embryonic stem (hES) cell lines, ESpan growth media for progenitor cell lines, and cell differentiation media for non-therapeutic uses, via its LifeMap BioReagents portal. LifeMap Sciences will utilize its databases as part of its online marketing strategy to reach life sciences researchers at biotech and pharmaceutical companies and at academic institutions and research hospitals worldwide.

In a therapeutic discovery collaboration with BioTime, LifeMaps scientists utilize LifeMaps proprietary platform, including LifeMap Discovery, its stem cell database along with the GeneCards and MalaCards integrated database suite, to aid in the development of BioTimes proprietary PureStem human progenitor cell lines into products for the treatment of human diseases, especially degenerative diseases that might be treatable with cell replacement therapies. The LifeMap Discovery platform will be used to select the progenitor cell lines that are most likely to facilitate the development of cell-based regenerative medicine therapies for a wide range of diseases.

About BioTime, Inc.

Read the original post:
BioTime and Subsidiary LifeMap Sciences Announce the Launch of LifeMap BioReagents™ Portal

Rhiannon, an Abused Dog, and Dakota, Get Stem Cell Therapy in Litchfield

By Stem Cell Treatment

LITCHFIELDWith a name inspired by a Celtic goddess who could manifest magic for the good of others, an Elkhound mix that suffered the depths of animal abusenearly to the point of deathis benefiting from cutting-edge veterinary medicine at a practice in Bantam.

Rhiannon, whose name derives from the Stevie Nicks song about the legendary goddess, is one of two patients helping to make veterinary history in Connecticut through the states first in-clinic stem cell regenerative therapy treatments.

Such loving care stands in stark contrast to the condition Rhiannons owner, Edward Milne of Cheshire, found the 14-year-old in the first time he saw her.

I found her hanging by her neck from a tree as I was driving along a back country road in Northford, CT when she was about two years old, Mr. Milne wrote in an e-mail to the Bantam clinic, Animal Health Practice Inc.

When I confronted the owner, Mr. Milne wrote, he admitted that he had not fed her or provided her with water for some time, and when she didnt die, he hung her from the tree to finish her off. I guess it was fate that brought us together.

Another type of Rhiannon-esque fate brought the dog to a vet who is performing a ground-breaking procedure to treat severe arthritis in her elbow and back.

Rhiannon is the first dog to receive MediVet Americas non-controversial adipose regenerative stem cell therapy, according to a release sent by the company. MediVet is a global leader in veterinary science located in 29 countries. The company develops advanced cellular treatments and natural herbal remedies designed to maximize animal performance, repair, recovery and general wellness.

Were very excited to be the first veterinarians in Connecticut to offer this new technology, said Dr. Angela Erickson-Greco Monday morning.

In addition to Rhiannon, Dr. Erickson-Greco is also administering the treatment to Dakota, a Bernese Mountain Dog and Great White Pyrenees mix, who has bilateral ACL tears, which means she has torn a crucial ligament in both of her knees.

New Milford resident Cathy Morsey said Dakota had a limp in her front leg in the shoulder area at 6 months old. In January of last year, we had a wet snow and she slid on the snow and tore a cartilage in her knee, said Ms. Morsey. Continued...

Continue reading here:
Rhiannon, an Abused Dog, and Dakota, Get Stem Cell Therapy in Litchfield

→←